Basic Information
| LncRNA/CircRNA Name | uc.63 |
| Synonyms | NA |
| Region | GRCh38_5:10627260-10628225 |
| Ensemble | ENSG00000250106 |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | breast cancer |
| ICD-0-3 | C50 |
| Methods | qPCR, RNAi, Western blot etc. |
| Sample | cell lines (MDA MB 231, MDA MB 468, BT-20, BT-549, BT-474 etc.) |
| Expression Pattern | up-regulated |
| Function Description | We found that overexpression of one specific T-UCRs named uc.63 is associated with bad outcome in luminal A subtype of breast cancer patients. |
| Pubmed ID | 27447964 |
| Year | 2016 |
| Title | Ultraconserved long non-coding RNA uc.63 in breast cancer. |
External Links
| Links for uc.63 | GenBank HGNC NONCODE |
| Links for breast cancer | OMIM COSMIC |